Kalle Mattila

Effectiveness of External Hemorrhage Compression Device of the Abdominal Aorta in Hemorrhagic Shock: A Systematic Review of the Literature (2025)

Journal of Special Operations Medicine

Kuusisto, Jaakko; Mattila, Kalle; Iirola, Timo; Heino, Anssi

(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä)

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma (2025)

BJUI COMPASS

Brännbäck, Anna; Mustonen, Ivan; Laajala, Teemu D.; Vainio, Paula; Lindskog, Magnus; Kjellman, Anders; Lundgren, Per-Olof; Jaakkola, Panu M.; Mattila, Kalle E.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study (2024)

Cancers

Virtanen Saana, Pihlman Heidi, Silvoniemi Maria, Vihinen Pia, Jaakkola Panu, Mattila Kalle E.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

The impact of prognostic factors and comorbidities on survival in older adults with stage I − III cutaneous melanoma in Southwest Finland: A register study (2024)

Journal of Geriatric Oncology

Mattila Kalle E., Vihinen Helmi, Heervä Eetu, Nuotio Maria S., Vihinen Pia

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma (2024)

Cancer Medicine

Luomala, Lassi; Mattila, Kalle; Vainio, Paula; Nisén, Harry; Pellinen, Teijo; Lohi, Jouni; Laajala, Teemu D.; Järvinen, Petrus; Koskenniemi, Anna‐Riina; Jaakkola, Panu; Mirtti, Tuomas

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma (2024)

Cancer Medicine

Luomala Lassi, Mattila Kalle, Vainio Paula, Nisén Harry, Pellinen Teijo, Lohi Jouni, Laajala Teemu D., Järvinen Petrus, Koskenniemi Anna-Riina, Jaakkola Panu, Mirtti Tuomas

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma (2023)

Acta Dermato-Venereologica

Mattila Kalle, Vihinen Helmi, Karlsson Antti, Minn Heikki, Vihinen Pia, Heervä Eetu

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Paikallisesti edenneen ihomelanooman hoito ja ihomelanooman esiliitännäishoito (2023)

Duodecim

Mattila Kalle, Veräjänkorva Esko, Koskivuo Ilkka, Heervä Eetu, Vihinen Pia, Hernberg Micaela

(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä)

Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy (2023)

Clinical Lung Cancer

Vihinen Hannes, Jokinen Artturi, Laajala Teemu D, Wahid Nesna, Peltola Lotta, Kettunen Tiia, Rönkä Aino, Tiainen Leena, Skyttä Tanja, Kohtamäki Laura, Tulokas Sanni, Karhapää Hanna, Hernberg Micaela, Silvoniemi Maria, Mattila Kalle E

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Observational study on the evolution of systemic treatments for advanced renal cell carcinoma in Southwest Finland between 2010 and 2021 (2023)

Therapeutic Advances in Urology

Hölsä Olivia, Teittinen Kaisa, Anttalainen Anna, Ukkola-Vuoti Liisa, Summanen Milla, Mattila Kalle E.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Kalle

Mattila

Contact

Publications

Sort by:

Effectiveness of External Hemorrhage Compression Device of the Abdominal Aorta in Hemorrhagic Shock: A Systematic Review of the Literature (2025)

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma (2025)

Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study (2024)

The impact of prognostic factors and comorbidities on survival in older adults with stage I − III cutaneous melanoma in Southwest Finland: A register study (2024)

Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma (2024)

Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma (2024)

Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma (2023)

Paikallisesti edenneen ihomelanooman hoito ja ihomelanooman esiliitännäishoito (2023)

Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy (2023)

Observational study on the evolution of systemic treatments for advanced renal cell carcinoma in Southwest Finland between 2010 and 2021 (2023)